physostigmine salicylate has been researched along with ibotenic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aggleton, JP; Aigner, TG; DeLong, MR; Mishkin, M; Mitchell, SJ; Price, DL; Struble, RG; Wenk, GL | 1 |
| Bringmann, A | 1 |
2 other study(ies) available for physostigmine salicylate and ibotenic acid
| Article | Year |
|---|---|
Effects of scopolamine and physostigmine on recognition memory in monkeys with ibotenic-acid lesions of the nucleus basalis of Meynert.
Topics: Acetylcholinesterase; Animals; Basal Ganglia; Brain Mapping; Choline O-Acetyltransferase; Cholinergic Fibers; Discrimination Learning; Dose-Response Relationship, Drug; Form Perception; Ibotenic Acid; Macaca fascicularis; Oxazoles; Pattern Recognition, Visual; Physostigmine; Receptors, Muscarinic; Scopolamine; Substantia Innominata | 1987 |
The pontomesencephalic tegmentum delays the peak latency of the visual evoked potential in rats.
Topics: Adrenergic Agonists; Animals; Atropine; Carbachol; Electroencephalography; Epinephrine; Evoked Potentials, Visual; Excitatory Amino Acid Agonists; Ibotenic Acid; Injections, Intraperitoneal; Male; Muscarinic Antagonists; Nicotine; Nicotinic Agonists; Physostigmine; Pons; Rats; Rats, Inbred Strains; Substantia Innominata; Tegmentum Mesencephali; Time Factors | 1995 |